Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
7.98
-0.03 (-0.37%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Puma Biotechnology Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 227.18 | 228.37 | 230.47 | 235.64 | 228.03 | 253.16 | |
Revenue Growth (YoY) | -2.38% | -0.91% | -2.19% | 3.34% | -9.92% | 12.46% |
Cost of Revenue | 58.03 | 58.16 | 64.4 | 62.68 | 55.09 | 63.7 |
Gross Profit | 169.15 | 170.21 | 166.06 | 172.96 | 172.94 | 189.45 |
Selling, General & Admin | 71.67 | 70.85 | 80.16 | 89.93 | 89.98 | 116.29 |
Research & Development | 68 | 62.07 | 54.94 | 50.38 | 52.24 | 71.87 |
Other Operating Expenses | - | - | - | - | 7 | - |
Total Operating Expenses | 139.67 | 132.92 | 135.1 | 140.32 | 149.22 | 188.16 |
Operating Income | 29.49 | 37.3 | 30.97 | 32.64 | 23.72 | 1.29 |
Interest Income | 3.98 | 4.08 | 4.72 | 2.61 | 0.81 | 0.16 |
Interest Expense | -5.18 | -6.62 | -12.45 | -13.33 | -11.59 | -12.81 |
Other Non-Operating Income (Expense) | 0.8 | 1.03 | 0.86 | 0.76 | -12.48 | -17.45 |
Total Non-Operating Income (Expense) | -0.4 | -1.52 | -6.87 | -9.97 | -23.26 | -30.09 |
Pretax Income | 29.09 | 35.78 | 24.1 | 22.67 | 0.46 | -28.8 |
Provision for Income Taxes | 1.46 | 4.67 | -6.18 | 1.08 | 0.46 | 0.32 |
Net Income | 24.38 | 31.11 | 30.28 | 21.59 | 0 | -29.13 |
Net Income to Common | 24.38 | 31.11 | 30.28 | 21.59 | 0 | -29.13 |
Net Income Growth | -35.95% | 2.75% | 40.23% | 1079450.00% | - | - |
Shares Outstanding (Basic) | 50 | 50 | 49 | 47 | 45 | 41 |
Shares Outstanding (Diluted) | 51 | 51 | 49 | 48 | 45 | 41 |
Shares Change (YoY) | 3.38% | 3.16% | 3.26% | 5.83% | 10.56% | 2.69% |
EPS (Basic) | 0.50 | 0.62 | 0.62 | 0.46 | - | -0.72 |
EPS (Diluted) | 0.48 | 0.61 | 0.62 | 0.45 | - | -0.72 |
EPS Growth | -37.66% | -1.61% | 37.78% | - | - | - |
Free Cash Flow | 53.6 | 41.73 | 38.86 | 26.87 | -15.83 | 20.65 |
Free Cash Flow Growth | 71.96% | 7.38% | 44.64% | - | - | 2740.44% |
Free Cash Flow Per Share | 1.05 | 0.82 | 0.79 | 0.57 | -0.35 | 0.51 |
Gross Margin | 74.46% | 74.53% | 72.06% | 73.40% | 75.84% | 74.84% |
Operating Margin | 12.98% | 16.33% | 13.44% | 13.85% | 10.40% | 0.51% |
Profit Margin | 10.73% | 13.62% | 13.14% | 9.16% | 0.00% | -11.51% |
FCF Margin | 23.59% | 18.27% | 16.86% | 11.40% | -6.94% | 8.16% |
EBITDA | 40.21 | 48.24 | 42.49 | 44.16 | 33.56 | 12.6 |
EBITDA Margin | 17.70% | 21.12% | 18.44% | 18.74% | 14.72% | 4.98% |
EBIT | 29.49 | 37.3 | 30.97 | 32.64 | 23.72 | 1.29 |
EBIT Margin | 12.98% | 16.33% | 13.44% | 13.85% | 10.40% | 0.51% |
Effective Tax Rate | 5.02% | 13.05% | -25.63% | 4.78% | 99.56% | -1.12% |